Mutual Recognition Procedure definition
Examples of Mutual Recognition Procedure in a sentence
The applicant should indicate the reference Member State, details of the marketing authorisation (date and number), procedure number, and for each “wave” of mutual recognition procedure concerned Member State(s) and the proposed (or agreed) common renewal date.The procedure number is the Mutual Recognition Procedure number allocated by the RMS.
Doris has not only incorporated multimedia meaningfully into her teaching but has managed to link online activity directly to the face-to-face lecture adding relevance and purpose to both.
In the Netherlands Copaxone 20 mg/ml (NL License RVG 30086) has been registered since 29 March 2004 through Mutual Recognition Procedure UK/H/0453/002.Since both authorisations for Copaxone are considered to belong to the same global marketing authorisation this approach is acceptable.
The product was approved through a Mutual Recognition Procedure (FR/H/0100/001).The Dutch amlodipine innovator product Norvasc 5 mg and 10 tablets (NL RVG 13348-13349) has been registered by Pfizer since June 1990 for the indications hypertension, chronic stable angina pectoris and vasospastic (Prinzmetal’s) angina.
Where a product has already been authorized for marketing in a Member State of the EEA, this National MA can be recognized in another Member States through the Mutual Recognition Procedure.
The amount of work involved should therefore be similar to that when UK is CMS in an Incoming Mutual Recognition Procedure.
As in all EU countries, pharmaceuticals can either be approved EU-wide by the EMA in the Centralized Procedure, or locally in the Decentralized Procedure, Mutual Recognition Procedure, or National Procedure.
HSA’s reference drug regulatory agencies are: • Australia Therapeutic Goods Administration (TGA);• Health Canada;• US Food and Drug Administration (FDA);• European Medicines Agency (EMA) via the Centralised Procedure; and• UK Medicines and Healthcare Products Regulatory Agency (UK MHRA) via- the national procedure; or- as the Reference Member State (RMS) via the Mutual Recognition Procedure or Decentralised Procedure on or prior to 31 January 2020 when the UK has formally left the European Union.
The innovator product was registered throughout the EU using one Mutual Recognition Procedure for both strengths, therefore, the innovator product marketed in the EU is expected to be identical.
This marketing authorization was for Copaxone powder for solution in vials containing 20 mg glatiramer acetate.In the Netherlands Copaxone 20 mg/ml (NL License RVG 30086) has been registered since 29 March 2004 through Mutual Recognition Procedure UK/H/0453/002.